• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用半自动机器人放射免疫分析法来测量人眼及其他细胞类型中由DP、EP2和IP前列腺素受体激活所产生的环磷酸腺苷(cAMP)。

Use of a semi-automated, robotic radioimmunoassay to measure cAMP generated by activation of DP-, EP2-, and IP-prostaglandin receptors in human ocular and other cell types.

作者信息

Crider J Y, Griffin B W, Xu S X, Sharif N A

机构信息

Alcon Laboratories (R2-43), Forth Worth, Texas 76134-2099, USA.

出版信息

Prostaglandins Leukot Essent Fatty Acids. 1998 Jul;59(1):77-82. doi: 10.1016/s0952-3278(98)90055-2.

DOI:10.1016/s0952-3278(98)90055-2
PMID:9758211
Abstract

The aim of these studies was to compare the effects of several prostaglandin agonists on adenylyl cyclase activity in embryonic bovine tracheal (EBTr) cells, transformed human nonpigmented ciliary epithelial (NPE) cells and National Cancer Bank (NCB-20) cells. These cell types have been shown to express DP, EP2 and IP prostaglandin (PG) receptors, respectively. Cyclic AMP (cAMP) generation was measured by manual and semi-automated radioimmunoassay (RIA) techniques. ZK118182 (EC50 = 10-27 nM), PGE2 (EC50 = 21-27 nM) and PGI2 (EC50 = 3.5-4 nM) had the highest potency at the DP, EP2 and IP receptors, respectively. A plot of potency (EC50) values generated with both techniques showed a high degree of correlation for all three receptors. These studies provide further characterization of prostanoid receptor functional responses in three cell types and demonstrate the advantages of a semi-automated RIA method for the analysis of the second messenger cAMP.

摘要

这些研究的目的是比较几种前列腺素激动剂对胚胎牛气管(EBTr)细胞、转化的人无色素睫状上皮(NPE)细胞和国家癌症库(NCB - 20)细胞中腺苷酸环化酶活性的影响。已证明这些细胞类型分别表达DP、EP2和IP前列腺素(PG)受体。通过手动和半自动放射免疫测定(RIA)技术测量环磷酸腺苷(cAMP)的生成。ZK118182(EC50 = 10 - 27 nM)、前列腺素E2(PGE2,EC50 = 21 - 27 nM)和前列腺素I2(PGI2,EC50 = 3.5 - 4 nM)分别在DP、EP2和IP受体上具有最高活性。用这两种技术生成的效价(EC50)值图显示,所有三种受体都具有高度相关性。这些研究进一步描述了三种细胞类型中前列腺素受体的功能反应,并证明了半自动RIA方法在分析第二信使cAMP方面的优势。

相似文献

1
Use of a semi-automated, robotic radioimmunoassay to measure cAMP generated by activation of DP-, EP2-, and IP-prostaglandin receptors in human ocular and other cell types.使用半自动机器人放射免疫分析法来测量人眼及其他细胞类型中由DP、EP2和IP前列腺素受体激活所产生的环磷酸腺苷(cAMP)。
Prostaglandins Leukot Essent Fatty Acids. 1998 Jul;59(1):77-82. doi: 10.1016/s0952-3278(98)90055-2.
2
Prostaglandin-stimulated adenylyl cyclase activity via a pharmacologically defined EP2 receptor in human nonpigmented ciliary epithelial cells.前列腺素通过人非色素睫状上皮细胞中药理学定义的EP2受体刺激腺苷酸环化酶活性。
J Ocul Pharmacol Ther. 1998 Aug;14(4):293-304. doi: 10.1089/jop.1998.14.293.
3
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.前列腺素DP受体在胚胎牛气管(EBTr)细胞中与腺苷酸环化酶正偶联:使用激动剂和拮抗剂的药理学特性研究
Br J Pharmacol. 1999 May;127(1):204-10. doi: 10.1038/sj.bjp.0702490.
4
Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.DP/EP2类前列腺素AL-6598的分子药理学及人眼DP和EP2受体位点的定量放射自显影可视化
J Ocul Pharmacol Ther. 2004 Dec;20(6):489-508. doi: 10.1089/jop.2004.20.489.
5
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.人嗜碱性粒细胞上表达的前列腺素(PG)结合位点的特征。前列腺素E1、I2和D2受体的证据。
J Biol Chem. 1992 Jun 25;267(18):12700-8.
6
Characterization of chimeric prostacyclin/prostaglandin D(2) receptors.嵌合前列环素/前列腺素D2受体的特性研究
Eur J Pharmacol. 1999 Dec 10;386(1):89-96. doi: 10.1016/s0014-2999(99)00725-6.
7
The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD or PGE.PGD 或 PGE 刺激下人 DP 和 EP2 前列腺素受体的磷酸二酯酶 4 的差异功能偶联。
Pharmacol Rep. 2021 Jun;73(3):946-953. doi: 10.1007/s43440-021-00247-x. Epub 2021 Mar 30.
8
Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.利用内源性受体研究天然和合成前列腺素的亲和力、选择性、效能及内在活性:聚焦于DP类前列腺素
J Pharmacol Exp Ther. 2000 May;293(2):321-8.
9
Human DP and EP2 prostanoid receptors take on distinct forms depending on the diverse binding of different ligands.人类二酰基甘油磷酸酯(DP)和前列腺素E2受体2(EP2)前列腺素受体根据不同配体的不同结合呈现出不同的形式。
FEBS J. 2016 Nov;283(21):3931-3940. doi: 10.1111/febs.13899. Epub 2016 Sep 29.
10
Pharmacology of functional endogenous IP prostanoid receptors in NCB-20 cells: comparison with binding data from human platelets.NCB - 20细胞中功能性内源性IP前列腺素受体的药理学:与来自人血小板的结合数据比较
Prostaglandins Leukot Essent Fatty Acids. 2001 Nov-Dec;65(5-6):253-8. doi: 10.1054/plef.2001.0322.

引用本文的文献

1
Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.抗过敏(依美斯汀;帕坦洛/帕迪特/帕泽奥)和抗青光眼(曲伏前列素;辛布林扎)眼科药物的研发至上市,以及新型药理学工具如AL - 8810的产生。
ACS Pharmacol Transl Sci. 2020 Nov 5;3(6):1391-1421. doi: 10.1021/acsptsci.0c00137. eCollection 2020 Dec 11.
2
Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.前列腺素 FP 受体拮抗剂:发现、药理学特性和治疗用途。
Br J Pharmacol. 2019 Apr;176(8):1059-1078. doi: 10.1111/bph.14335. Epub 2018 Jun 7.
3
Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand.
使用DP受体选择性拮抗剂放射性配体[(3)H]-BWA868C对人DP前列腺素受体进行的药理学与放射自显影研究
Br J Pharmacol. 2000 Nov;131(6):1025-38. doi: 10.1038/sj.bjp.0703686.
4
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.[(3)H]-前列腺素E(2)与克隆的人EP(4)类前列腺素受体结合的药理学特性
Br J Pharmacol. 2000 Aug;130(8):1919-26. doi: 10.1038/sj.bjp.0703525.